Pediatric Emergency Medicine Journal Club

Needs Statement

Faculty, fellows, and residents in pediatric emergency medicine need to receive regular updates on recent advances in the emergency care of children. With a unique scope of practice, pediatric emergency medicine encompasses various general and subspecialty disciplines, including pediatrics, surgery, and critical care. Experts in these disciplines will review professional guidelines and research results related to the stabilization, management, and treatment of acutely ill and injured children as an impetus for discussion. The series aims to expand the knowledge of learners, promote the implementation of evidence-based guidelines in clinical practice, enhance the quality of pediatric emergency care, and improve patient outcomes.

Educational Objectives

At the conclusion of the sessions, the participants should be able to:

• Distinguish between the designs for a superiority randomized control trial (RCT) and an inferiority RCT.
• Interpret confidence intervals and their significance in non-inferiority trials.
• Determine if results from non-inferiority RCTs apply to a pediatric emergency medicine setting.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.